首页> 外文期刊>Acta Neurochirurgica >Enhanced recovery and accelerated discharge after endoscopic transsphenoidal pituitary surgery: safety, patient feedback, and cost implications
【24h】

Enhanced recovery and accelerated discharge after endoscopic transsphenoidal pituitary surgery: safety, patient feedback, and cost implications

机译:内镜下垂体垂体手术后增强恢复和加速放电:安全,患者反馈和成本影响

获取原文
获取原文并翻译 | 示例
           

摘要

Background Enhanced recovery after surgery (ERAS) is a constant motivation. There is growing evidence that an endoscopic (rather than microscopic) transsphenoidal approach to pituitary tumours can play a role, facilitating faster recovery and a commensurate reduction in length of stay (LOS). Reducing LOS is beneficial to both patients and healthcare systems. We sought to assess the safety, patient feedback, and resource implications of adopting an enhanced recovery and accelerated discharge policy for elective pituitary surgery. Methods We retrospectively assessed two consecutive cohorts of patients undergoing elective surgery for pituitary adenoma in a single UK centre between July 2016 and November 2019. The pre-ERAS cohort included 52 sequential patients operated prior to protocol change. The ERAS cohort included 55 sequential patients operated after a protocol change. Patient demographic data, tumour characteristics, intra- and post-operative CSF leak, the rate and cause of readmission (within 30 days), and the mean and median LOS were recorded. Patient feedback was collected from a subset of patients (n = 23) in the ERAS group. Results The two cohorts were well-matched with respect to their demographic, pathological, and operative characteristics. The rates of readmission within 30 days of discharge were similar between the two groups (8% pre-ERAS cohort, 9% ERAS cohort, p = 0.75). In the pre-ERAS cohort, the mean LOS was 4.5 days and median LOS was 3 days. This compares with significant reduction in LOS for the ERAS group: mean of 1.7 days and median of 1 day (p < 0.05). Thirty-nine of 55 patients in the ERAS group were discharged on post-operative day 1. Patient feedback was very positive in the ERAS group (mean patient satisfaction score of 9.7/10 using a Likert scale). Conclusions An enhanced recovery protocol after elective endoscopic pituitary surgery is safe, reduces length of stay, and is associated with high patient satisfaction.
机译:手术后的背景增强恢复(ERAS)是一种恒定的动机。越来越多的证据表明,内窥镜(而不是微观)垂体肿瘤的晶状体方法可以发挥作用,促进更快的恢复和逗留时间的常规减少(LOS)。减少洛杉矶有利于患者和医疗保健系统。我们试图评估采用增强型垂体手术的恢复和加速排放政策的安全,患者反馈和资源影响。方法方法回顾性评估了2016年7月和2019年11月在一家英国中心垂体腺瘤中接受选修腺瘤的患者的两次连续群组。在议定书变更前包括52名连续的患者。 Eras Cohort包括55例顺序患者在协议变更后运行。患者人口统计数据,肿瘤特征,术语和后术后CSF泄漏,入院的速率和原因(30天内)和均值和中位数洛斯。从ERAS组中的患者(n = 23)的子集中收集患者反馈。结果,两组队列与其人口统计学,病理和手术特征均匀匹配。在排出后30天内的阅许率在两组之间相似(8%的ERAS队列,9%Eras Cohort,P = 0.75)。在正式前的队列中,平均洛杉矶为4.5天,中位数洛斯是3天。这与ERAS组的显着减少相比:1天的1.7天和中位数(P <0.05)。术后第三十九名患者中有35例患者在操作后的一天中排出1.患者反馈在ERAS组中非常阳性(使用李克特量表的平均患者满意度得分为9.7 / 10)。结论选修内镜垂体手术后的增强型回收方案是安全的,降低了逗留时间,与高病患满意度有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号